The Impact of Programmed Death-Ligand 1 Expression on the Prognosis of Early Stage Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Literatures

INTRODUCTION: Previous studies have demonstrated that programmed cell death-ligand 1 (PD-L1) serves as biomarker for poor prognosis and survival in advanced-stage non-small cell lung cancer (NSCLC) patients. However, the merit of PD-L1 expression to predict the prognosis of early stage NSCLC patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Tao, Zhu, Shuai, Guo, Hengjuan, Li, Xiongfei, Zhao, Shikang, Wang, Yanye, Lei, Xi, Huang, Dingzhi, Peng, Ling, Li, Ziming, Xu, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940546/
https://www.ncbi.nlm.nih.gov/pubmed/33708622
http://dx.doi.org/10.3389/fonc.2021.567978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940546/
https://www.ncbi.nlm.nih.gov/pubmed/33708622
http://dx.doi.org/10.3389/fonc.2021.567978

Ejemplares similares